
DNAmito's proprietary DNA technology enables oncologists to deliver targeted radiation therapy with genomic precision, improving clinical outcomes while streamlining care delivery.
Prodecis is a decision support system that helps patients and their physicians determine the efficacy of proton or photon treatment using dose planning comparison and complication risk evaluation. Prodecis uses multiple factors such as biological, genetic, clinical and imaging information about the patient to compare various treatment options. Prodecis helps radiation oncologists select the best treatment path for each patient.

DNAMito enable personalization of treatment. Radiation therapy may be personalized based on multiple factors specific to a patient – including genetic information. Oncologists will greatly benefit from the decision support system that helps them integrate multiple patient factors in the treatment decisions.

